Arbutus Biopharma Corp (ABUS) Peer Comparison
$3.74
As on 05-Nov-2026 14:39EST
Market cap
$645 Mln
Revenue (TTM)
$182 Mln
P/E Ratio
5.3
P/B Ratio
3.2
Div. Yield
0 %
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
645 | 3,069 | 1,216 | 304 | 293 |
Revenue ($ Mln) |
182 | 11,084 | 225 | 920 | 321 |
Net Profit ($ Mln) |
153.05 | -841.00 | 69.79 | -58.67 | -259.27 |
Net Margin (%) |
84.23 | -7.59 | 30.98 | -6.38 | -80.67 |
RoE (%) |
91.29 | -- | 5.60 | -5.59 | -29.99 |
Price to Earnings |
5.33 | -- | 17.37 | -- | -- |
Price-To-Book |
3.23 | 18.78 | 1.14 | 0.42 | 0.56 |
Cashflow ($ Mln)
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-39.64 | 1,400.00 | 26.32 | 70.92 | -165.75 |
|
Cash Flow from Investing Activities
|
15.58 | -595.00 | -77.90 | 17.45 | -47.79 |
|
Cash from Financing Activities
|
5.72 | -742.00 | -20.25 | -54.49 | 148.66 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-36.37 | 0.76 | -0.89 | -1.23 | -59.69 |
|
ROE (%)
|
91.29 | -17.14 | 5.60 | -5.59 | -29.99 |
|
ROA (%)
|
79.37 | -4.45 | 5.70 | -4.31 | -22.80 |
|
EBIT Margin (%)
|
84.27 | 11.19 | -1.28 | -1.16 | -71.05 |
|
Net Margin (%)
|
84.23 | -7.59 | 30.98 | -6.38 | -80.67 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
1,078.78 | 10.52 | 72.88 | -3.33 | 16.90 |
|
EBIT Growth (%)
|
367.23 | -41.29 | 92.87 | 88.29 | 49.49 |
|
Net Profit Growth (%)
|
382.12 | -332.32 | 277.46 | 36.42 | 49.41 |
|
EPS Growth (%)
|
374.07 | -272.48 | 281.14 | 32.91 | 85.64 |
|
Book Value Growth (%)
|
203.81 | -258.65 | -1.26 | -3.91 | -37.19 |
Valuation Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-27.51 | 16.40 | -105.42 | -27.71 | -0.16 |
|
Price / Book Value
|
12.04 | -4.66 | 0.93 | 0.40 | 0.20 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-25.25 | 7.07 | -54.50 | 6.96 | -0.66 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | -14.89 | 0.00 | 0.00 | 0.31 |
|
Short term debt to equity ratio
|
0.00 | 0.00 | 0.00 | 0.04 | 0.06 |
|
Current Ratio
|
81.42 | 23.44 | 16.18 | 3.92 | 3.04 |
|
Quick Ratio
|
81.42 | 18.41 | 15.25 | 2.34 | 2.39 |
|
Interest Coverage
|
2,014.87 | 0.78 | -- | -8.99 | -4.92 |
Operating Efficiency Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
98.91 | 22.85 | 23.12 | 3.80 | 13.25 |
|
Asset Turnover
|
0.94 | 0.59 | 0.18 | 0.68 | 0.28 |
|
Receivable days
|
53.89 | 79.82 | 106.48 | 11.30 | 71.03 |
|
Inventory Days
|
-- | 195.23 | 166.85 | 68.84 | 167.38 |
|
Payable days
|
1,755.31 | 76.06 | 59.75 | 14.63 | 52.79 |
|
Cash Conversion Cycle
|
-- | 198.99 | 213.59 | 65.51 | 185.62 |